A protest over a draft decision not to recommend a new cystic fibrosis drug is due later. Campaigners keen to see Kalydeco introduced across Wales are aiming to make their voices heard outside a meeting of the All Wales Medicines Strategy Group at the Angel Hotel in Abergavenny.
The group will look at the recommendation and decide whether to approve it or not. The drug - which is already available in England, Scotland and Northern Ireland - is the first licensed drug that treats the G551D mutation - the fundamental defect in those with cystic fibrosis.
More top news
A schoolboy's life could have been saved if two GPs had provided immediate medical intervention, a court has heard.
It seems our patience has been rewarded! Things are settling down, the sun is shining and temperatures are on the up!
It's that time of the year! As the weather settles pollen levels start to rise! Tree pollen is particularly high this week!